Switching from Adalimumab Originator to Biosimilar in Patients with Hidradenitis Suppurativa Results in Losses of Response-Data from the German HS Registry HSBest - Kirsten, N; Ohm, F; Gehrdau, K (Life (Basel), 2022)
et al.